Medeor Therapeutics

About:

Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.

Website: https://www.medeortx.com/

Top Investors: RA Capital Management, Sofinnova Investments, Vivo Capital, 6 Dimensions Capital, California Institute for Regenerative Medicine

Description:

Medeor Therapeutics is a developer of cellular immunotherapies designed to improve outcomes in organ transplant recipients. The company's cellular immunotherapies consist of approaches to organ transplant immune tolerance and immuno-oncology, enabling healthcare providers to preserve or improve transplant kidney function and prevent graft rejection better than currently available immunosuppression (anti-rejection) drugs.